Form 4: BioMarin Executive George Eric Davis Reports Stock Transactions

Executive Vice President and Chief Legal Officer of BioMarin Pharmaceutical, George Eric Davis, reports acquisition and disposal of company stock, including transactions under a 10b5-1 plan and the Employee Stock Purchase Plan.

Summary

• George Eric Davis, EVP and Chief Legal Officer of BioMarin Pharmaceutical Inc., filed a Form 4 detailing changes in beneficial ownership.
• On April 30, 2024, Davis acquired 301 shares of common stock through the Employee Stock Purchase Plan at $68.646 per share.
• On May 2, 2024, Davis exercised options to acquire 1,850 shares at $63.1 per share and simultaneously sold 1,850 shares at a weighted average price of $85.01 per share.
• These transactions were made pursuant to a 10b5-1 plan executed on September 13, 2023.
• Following these transactions, Davis directly owns 56,157 shares of common stock and holds options for 40,850 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports stock transactions by an executive, which is a routine activity. There is no indication of positive or negative sentiment towards the company's performance.

Positives

• The executive's participation in the Employee Stock Purchase Plan indicates confidence in the company's future.
• The 10b5-1 trading plan ensures compliance with insider trading regulations.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's performance and future prospects. The use of 10b5-1 plans is a standard practice to allow insiders to trade company stock while avoiding accusations of insider trading.

Comparison to Industry Standards

• Executive stock ownership and trading activity are typical for publicly traded companies like BioMarin.
• Companies such as Amgen, Gilead Sciences, and Vertex Pharmaceuticals also see regular Form 4 filings from their executives.
• The use of 10b5-1 plans is a widespread practice among executives at comparable companies to manage their stock transactions in compliance with regulations.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the relatively small volume of shares traded.
• The Employee Stock Purchase Plan benefits employees by allowing them to acquire company stock at a potentially discounted price.

Key Dates